ONCAlert | Upfront Therapy for mRCC
News
Acalabrutinib Added to BR Induces Responses in 90% in Mantle Cell Lymphoma
5:25 PM, Tue December 11, 2018
Wierda Compares Treatment Options for Patients With CLL
4:17 PM, Tue December 11, 2018
Merkel 200 Analyses Support Avelumab Benefit in Merkel Cell Carcinoma
9:41 PM, Mon December 10, 2018
Eng Provides Insight on Current Treatment Paradigm of GI Cancers
5:47 PM, Mon December 10, 2018
No Survival Benefit Found With Durvalumab in Head and Neck Cancer
5:03 PM, Mon December 10, 2018
Phase III Trial Evaluating Rova-T in Small Cell Lung Cancer Put on Hold
7:25 PM, Fri December 7, 2018
O'Malley Discusses the Role of Bevacizumab Maintenance in an Ovarian Cancer Case Study
3:15 PM, Fri December 7, 2018
FDA Grants Approval to Frontline Atezolizumab Regimen for NSCLC
9:34 PM, Thu December 6, 2018
